HUP0004134A2 - Determination of cellular growth abnormality - Google Patents

Determination of cellular growth abnormality

Info

Publication number
HUP0004134A2
HUP0004134A2 HU0004134A HUP0004134A HUP0004134A2 HU P0004134 A2 HUP0004134 A2 HU P0004134A2 HU 0004134 A HU0004134 A HU 0004134A HU P0004134 A HUP0004134 A HU P0004134A HU P0004134 A2 HUP0004134 A2 HU P0004134A2
Authority
HU
Hungary
Prior art keywords
determination
cellular growth
growth abnormality
abnormality
cellular
Prior art date
Application number
HU0004134A
Other languages
English (en)
Inventor
Nicholas Coleman
Ronald Alfred Laskey
Gareth Haydn Williams
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9722217.8A external-priority patent/GB9722217D0/en
Priority claimed from GBGB9724134.3A external-priority patent/GB9724134D0/en
Priority claimed from GBGB9804156.9A external-priority patent/GB9804156D0/en
Priority claimed from GBGB9810560.4A external-priority patent/GB9810560D0/en
Priority claimed from GBGB9817075.6A external-priority patent/GB9817075D0/en
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of HUP0004134A2 publication Critical patent/HUP0004134A2/hu

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Liquid Crystal Substances (AREA)
  • Eye Examination Apparatus (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU0004134A 1997-10-21 1998-10-21 Determination of cellular growth abnormality HUP0004134A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9722217.8A GB9722217D0 (en) 1997-10-21 1997-10-21 Determination of cellular growth abnormality
GBGB9724134.3A GB9724134D0 (en) 1997-11-14 1997-11-14 Determination of cellular growth abnormality
GBGB9804156.9A GB9804156D0 (en) 1998-02-26 1998-02-26 Determination of cellular growth abnormality
GBGB9810560.4A GB9810560D0 (en) 1998-05-15 1998-05-15 Determination of cellular growth abnormality
GBGB9817075.6A GB9817075D0 (en) 1998-08-05 1998-08-05 Determination of cellular growth abnormality
PCT/GB1998/003153 WO1999021014A1 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality

Publications (1)

Publication Number Publication Date
HUP0004134A2 true HUP0004134A2 (en) 2001-03-28

Family

ID=27517431

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004134A HUP0004134A2 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality

Country Status (23)

Country Link
EP (1) EP1025444B1 (hu)
JP (2) JP2000511291A (hu)
CN (1) CN1282422A (hu)
AT (1) ATE290213T1 (hu)
AU (1) AU751754B2 (hu)
BR (1) BR9813127A (hu)
CA (1) CA2305872C (hu)
CO (1) CO5080817A1 (hu)
DE (1) DE69829198T2 (hu)
DK (1) DK1025444T3 (hu)
ES (1) ES2239407T3 (hu)
GB (1) GB2332515B (hu)
HU (1) HUP0004134A2 (hu)
IL (1) IL135602A0 (hu)
IS (1) IS5456A (hu)
MA (1) MA26557A1 (hu)
NO (1) NO20002044L (hu)
NZ (1) NZ503996A (hu)
PE (1) PE20000121A1 (hu)
PL (1) PL340057A1 (hu)
PT (1) PT1025444E (hu)
SK (1) SK5592000A3 (hu)
WO (1) WO1999021014A1 (hu)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361954B1 (en) 1996-05-02 2002-03-26 Cold Spring Harbor Laboratory Methods of immunoassay for human CDC6
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
DE10063112A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
IL157872A0 (en) 2001-03-12 2004-03-28 Monogen Inc A panel for detecting a generic disease state containing a plurality of probes and using cell-based diagnosis
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
EP2311978A1 (en) * 2002-08-20 2011-04-20 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
EP1422526A1 (en) 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
EP1620449A4 (en) * 2003-02-14 2008-10-01 Smithkline Beecham Corp NUCLEIC ACIDS WITH DIFFERENTIAL EXPRESSION THAT CORRELATE WITH KSP EXPRESSION
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
WO2005038044A1 (ja) * 2003-10-20 2005-04-28 Sysmex Corporation 細胞処理方法
EP1756577B1 (en) 2004-03-24 2012-03-14 Tripath Imaging, Inc. Methods and compositions for the detection of cervical disease
US7595380B2 (en) 2005-04-27 2009-09-29 Tripath Imaging, Inc. Monoclonal antibodies and methods for their use in the detection of cervical disease
GB0518877D0 (en) * 2005-09-15 2005-10-26 Medical Res Council Markers and methods
US7632498B2 (en) 2005-12-19 2009-12-15 Tripath Imaging, Inc. MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
ES2461189T3 (es) 2006-01-05 2014-05-19 The Ohio State University Research Foundation Métodos basados en microARN y composiciones para el diagnóstico y el tratamiento de cánceres sólidos de mama o pulmón
EP2369012A1 (en) 2006-03-20 2011-09-28 The Ohio State University Research Foundation Micro-RNA fingerprints during human megakaryocytopoiesis
DE102006020852A1 (de) 2006-05-04 2007-11-15 Robert Bosch Gmbh Gasdruckbehälter für gasbetriebene Kraftfahrzeuge
ES2627059T3 (es) 2007-08-03 2017-07-26 The Ohio State University Research Foundation Regiones ultraconservadas que codifican ARNnc
GB0811567D0 (en) 2008-06-24 2008-07-30 Cytosystems Ltd Assay
EP2504452A4 (en) 2009-11-23 2014-06-11 Univ Ohio State Res Found SUBSTANCES AND METHODS THAT CAN BE USED TO ACT ON THE GROWTH, MIGRATION, AND INVASION OF TUMOR CELLS
GB0921873D0 (en) 2009-12-15 2010-01-27 Cytosystems Ltd Assay
AU2011326032B2 (en) 2010-11-12 2016-10-06 The Ohio State University Research Foundation Materials and methods related to microRNA-21, mismatch repair, and colorectal cancer
BR112013011942A2 (pt) 2010-11-15 2016-11-01 Univ Michigan formulação, forma de dosagem de droga para administração transmucosa oral, sistema transmucoso de fornecimento de droga, método de tratamento e profilaxia de uma doença ou distúrbio, método de tratamento, formulação, método para tratamento ou prevenção de carcinoma de célula escamosa de cabeça e pescoço (hnscc), método para quimioprevenção de um câncer oral ou condição pré-cancerosa, método para aumentar a concentração de uma composição de retinida, método de tratamento e profilaxia de uma doença ou condição, método de ratamento de um sujeito apresentando uma condição médica sintomática, método de tratamento de um câncer oral ou condição pré-cancerosa num paciente, método para fazer um sistema de fornecimento de droga bucal, método para aumentar a liberação e permeação de uma composição de retinida.
WO2012090479A1 (en) * 2010-12-28 2012-07-05 Oncotherapy Science, Inc. Mcm7 as a target gene for cancer therapy and diagnosis
JP2014530612A (ja) 2011-10-14 2014-11-20 ジ・オハイオ・ステート・ユニバーシティ 卵巣がんに関する方法および材料
CN104619353A (zh) 2011-12-13 2015-05-13 俄亥俄州国家创新基金会 与miR-21和miR-29a相关的方法和组合物、外切体抑制和癌症转移
CN104145030B (zh) * 2012-01-05 2016-10-12 国家科学研究中心 用于诊断肺癌侵袭性和遗传不稳定性的标记
JP2015511121A (ja) 2012-01-20 2015-04-16 ジ・オハイオ・ステート・ユニバーシティ 浸潤性および予後に関する乳がんバイオマーカーシグネチャー
US11306364B2 (en) 2012-02-18 2022-04-19 Duke University TERT promoter mutations in gliomas and a subset of tumors
KR101832948B1 (ko) * 2013-02-18 2018-02-28 듀크 유니버시티 신경교종 및 종양의 서브세트 내 tert 프로모터 돌연변이
GB201412731D0 (en) * 2014-07-17 2014-09-03 Immunocore Ltd & Adaptimmune Ltd Peptides
CA2984701C (en) * 2015-05-10 2023-09-26 Ventana Medical Systems, Inc. Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays
US11391744B2 (en) 2015-06-08 2022-07-19 Arquer Diagnostic Limited Methods and kits
ES2806498T3 (es) 2015-06-08 2021-02-17 Arquer Diagnostics Ltd Métodos para el análisis de una muestra de orina
GB201509907D0 (en) * 2015-06-08 2015-07-22 Urosens Ltd Antibodies
GB201511196D0 (en) 2015-06-25 2015-08-12 Cytosystems Ltd Monoclonal antibodies
JP6245299B2 (ja) * 2016-04-27 2017-12-13 バクスアルタ ゲーエムベーハー 組換え安定細胞クローン、その産生およびその使用
CN106636343B (zh) * 2016-11-04 2021-03-19 深圳大学 一种检测口腔癌的标志物及其试剂盒
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
CN112946253B (zh) * 2019-12-11 2022-11-08 广东菲鹏生物有限公司 用于免疫诊断试剂中固相载体的封闭阶段处理剂及应用和产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1320689C (en) * 1984-03-30 1993-07-27 Alain Schreiber Monoclonal antibody specific for human basal cell surface antigen
US5851821A (en) * 1996-05-02 1998-12-22 Cold Spring Harbor Laboratory DNA Replication-regulating genes
EP0812594A1 (en) * 1996-06-13 1997-12-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Compounds that interfere with DNA replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer

Also Published As

Publication number Publication date
GB9823069D0 (en) 1998-12-16
MA26557A1 (fr) 2004-12-20
CO5080817A1 (es) 2001-09-25
EP1025444B1 (en) 2005-03-02
CA2305872A1 (en) 1999-04-29
AU9550298A (en) 1999-05-10
NO20002044D0 (no) 2000-04-18
PL340057A1 (en) 2001-01-15
IL135602A0 (en) 2001-05-20
JP2000511291A (ja) 2000-08-29
ATE290213T1 (de) 2005-03-15
BR9813127A (pt) 2000-08-15
DE69829198D1 (de) 2005-04-07
CN1282422A (zh) 2001-01-31
DK1025444T3 (da) 2005-06-27
GB2332515A (en) 1999-06-23
IS5456A (is) 2000-04-17
GB2332515B (en) 1999-12-15
EP1025444A1 (en) 2000-08-09
DE69829198T2 (de) 2006-01-12
JP2003240786A (ja) 2003-08-27
PE20000121A1 (es) 2000-02-17
ES2239407T3 (es) 2005-09-16
CA2305872C (en) 2008-02-19
AU751754B2 (en) 2002-08-29
JP3774196B2 (ja) 2006-05-10
NO20002044L (no) 2000-06-07
PT1025444E (pt) 2005-07-29
SK5592000A3 (en) 2000-10-09
NZ503996A (en) 2002-04-26
WO1999021014A1 (en) 1999-04-29

Similar Documents

Publication Publication Date Title
HUP0004134A2 (en) Determination of cellular growth abnormality
IL134871A0 (en) Polymeric derivatives of campothecins
PL339551A1 (en) Derivatives of rezorcin
GB9719965D0 (en) Modified bioreactor
IL114914A0 (en) Modulation of cellular activity
GB9712696D0 (en) Bandage
HUP9702242A3 (en) Inozitol-glykanes of inzulin-like activity
ZA9810252B (en) Grip-aid bandage
PL334769A1 (en) Derivatives of 5-aroylnaphtene
GB9820532D0 (en) Modified bioreactor
ZA985064B (en) Derivatives of pentaerythrits
GB9708078D0 (en) Bandage
IL125094A0 (en) Growth medium
ZA989413B (en) Determination of cellular growth abnormality
GB9724134D0 (en) Determination of cellular growth abnormality
PL328221A1 (en) Novel derivatives of urea
GB9817075D0 (en) Determination of cellular growth abnormality
GB9810560D0 (en) Determination of cellular growth abnormality
GB9804156D0 (en) Determination of cellular growth abnormality
PL325816A1 (en) Novel derivatives of naphtylpiperazine
GB2328096B (en) Cellular circuitry
EP0891372A4 (en) HTTR36 GROWTH FACTOR
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
ZA957223B (en) Modulation of cellular activity
GB9719794D0 (en) Growth Factors